Follow-The-Filings

Security · featured owners

NRIX Nurix Therapeutics Inc

Nurix Therapeutics Inc. COMMON STOCK Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.3%
  • $44M
  • 1 add

Who owns this now

Largest portfolio weights among featured holders · max 0.3% (Cathie Wood - Ark Investm...) · not free-float ownership

  1. Cathie Wood add 0.28%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Cathie Wood - Ark Investment Management 2026 Q2 0.28% Add +4.2% 1,793,196 $44M history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 10 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
8-K 5.07,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 25 shown

Filed Form Detail Links
4 Period Aug 4, 2026 Filing Doc
4 Period Aug 5, 2026 Filing Doc
4 Period Aug 4, 2026 Filing Doc
4 Period Aug 3, 2026 Filing Doc
4 Period Jul 30, 2026 · 3 forms Filing Doc
4 Period Jul 2, 2026 Filing Doc
4 Period Jun 25, 2026 · 2 forms Filing Doc
4 Period Jun 2, 2026 Filing Doc
4 Period May 15, 2026 · 8 forms Filing Doc
4 Period May 5, 2026 Filing Doc
4 Period May 4, 2026 Filing Doc
4 Period May 1, 2026 Filing Doc
4 Period Apr 30, 2026 · 3 forms Filing Doc

Updated 7 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — $54.55M $83.98M
Net income -$143.95M -$193.57M -$264.46M
Net margin * — -354.9% -314.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $295.5M $619.39M $606.82M
Total non-current assets * $60.1M $49.96M $81.32M
Total assets $355.6M $669.34M $688.14M
Total current liabilities $86.96M $95.85M $86.47M
Total non-current liabilities * $68.15M $46.5M $62.92M
Total equity $200.49M $526.99M $538.75M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$81.36M -$172.58M -$249.46M
Cash from investing $68.3M -$257.71M $147.85M
Cash from financing $3.22M $485.67M $238.64M
Net change in cash -$9.85M $55.37M $137.03M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders